Full name : Geerts Hugo
First name : Hugo
Mail : Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
Zip Code :
City :
Country : USA
Email : Hugo-Geerts@In-Silico-Biosciences.com
Phone :
Fax :
Website :
Directory :
Comment
| Title : Simulations of symptomatic treatments for Alzheimer's disease: computational analysis of pathology and mechanisms of drug action - Roberts_2012_Alzheimers.Res.Ther_4_50 |
| Author(s) : Roberts PD , Spiros A , Geerts H |
| Ref : Alzheimers Res Ther , 4 :50 , 2012 |
| Abstract : |
| PubMedSearch : Roberts_2012_Alzheimers.Res.Ther_4_50 |
| PubMedID: 23181523 |
| Title : Beyond in vitro data: a review of in vivo evidence regarding the allosteric potentiating effect of galantamine on nicotinic acetylcholine receptors in Alzheimer's neuropathology - Coyle_2007_J.Alzheimers.Dis_11_491 |
| Author(s) : Coyle JT , Geerts H , Sorra K , Amatniek J |
| Ref : J Alzheimers Dis , 11 :491 , 2007 |
| Abstract : |
| PubMedSearch : Coyle_2007_J.Alzheimers.Dis_11_491 |
| PubMedID: 17656829 |
| Title : Pharmacology of acetylcholinesterase inhibitors and N-methyl-D-aspartate receptors for combination therapy in the treatment of Alzheimer's disease - Geerts_2006_J.Clin.Pharmacol_46_8S |
| Author(s) : Geerts H , Grossberg GT |
| Ref : Journal of Clinical Pharmacology , 46 :8S , 2006 |
| Abstract : |
| PubMedSearch : Geerts_2006_J.Clin.Pharmacol_46_8S |
| PubMedID: 16809810 |
| Title : [Pharmacology of Alzheimer's disease: where do we go from here?] - Sellal_2005_Therapie_60_89 |
| Author(s) : Sellal F , Nieoullon A , Michel G , Michel BF , Lacomblez L , Geerts H , Delini-Stula A , Bentue-Ferrer D , Bordet R , Allain H |
| Ref : Therapie , 60 :89 , 2005 |
| Abstract : |
| PubMedSearch : Sellal_2005_Therapie_60_89 |
| PubMedID: 15969312 |
| Title : Indicators of neuroprotection with galantamine - Geerts_2005_Brain.Res.Bull_64_519 |
| Author(s) : Geerts H |
| Ref : Brain Research Bulletin , 64 :519 , 2005 |
| Abstract : |
| PubMedSearch : Geerts_2005_Brain.Res.Bull_64_519 |
| PubMedID: 15639548 |
| Title : Brain levels and acetylcholinesterase inhibition with galantamine and donepezil in rats, mice, and rabbits - Geerts_2005_Brain.Res_1033_186 |
| Author(s) : Geerts H , Guillaumat PO , Grantham C , Bode W , Anciaux K , Sachak S |
| Ref : Brain Research , 1033 :186 , 2005 |
| Abstract : |
| PubMedSearch : Geerts_2005_Brain.Res_1033_186 |
| PubMedID: 15694923 |
| Title : Nicotinic receptor modulation: advantages for successful Alzheimer's disease therapy - Geerts_2002_J.Neural.Transm.Suppl_62_203 |
| Author(s) : Geerts H , Finkel L , Carr R , Spiros A |
| Ref : J Neural Transm Suppl , 62 :203 , 2002 |
| Abstract : |
| PubMedSearch : Geerts_2002_J.Neural.Transm.Suppl_62_203 |
| PubMedID: 12456064 |
| Title : The rationale behind cholinergic drug treatment for dementia related to cerebrovascular disease - Grantham_2002_J.Neurol.Sci_203-204_131 |
| Author(s) : Grantham C , Geerts H |
| Ref : Journal of Neurology Sci , 203-204 :131 , 2002 |
| Abstract : |
| PubMedSearch : Grantham_2002_J.Neurol.Sci_203-204_131 |
| PubMedID: 12417371 |
| Title : Nicotinic cholinergic modulation: galantamine as a prototype - Woodruff-Pak_2002_CNS.Drug.Rev_8_405 |
| Author(s) : Woodruff-Pak DS , Lander C , Geerts H |
| Ref : CNS Drug Rev , 8 :405 , 2002 |
| Abstract : |
| PubMedSearch : Woodruff-Pak_2002_CNS.Drug.Rev_8_405 |
| PubMedID: 12481195 |